TGFβ1 has been identified as a confirmed target of both miR-21-5p and miR-146a-5p [45], with overexpression of oncogenic miR-21 in NSCLC cells involving decreased TGFβ1 and aberrant cell proliferation [46]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.